APTEVO THERAPEUTICS INC (APVO)
US03835L3069 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.73M | 1.10M | 3.80M | 4.60M | 5.00M | |||
| Cash Equivalents | 13.17M | 21.60M | 41.20M | 35.40M | 7.50M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 0.00 | 2.50M | 3.70M | 2.40M | 7.00M | |||
| Inventories | N/A | N/A | N/A | N/A | 6.10M | |||
| Other Current Assets | 2.16M | 2.30M | 3.80M | 4.90M | 4.40M | |||
| Total Current Assets | 19.07M | 27.50M | 52.60M | 47.30M | 30.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.78M | 6.80M | 4.00M | 5.50M | 7.70M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | 4.40M | |||
| Other Non-Current Assets | N/A | 0.00 | 100.00K | 700.00K | 11.30M | |||
| Total Non-Current Assets | 5.78M | 6.70M | 4.00M | 6.20M | 23.40M | |||
| TOTAL ASSETS | 24.84M | 34.20M | 56.60M | 53.50M | 53.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 2.00M | 11.70M | 5.00M | 19.90M | |||
| Accrued Expenses | 2.80M | 2.50M | 3.10M | 3.70M | 4.50M | |||
| Accounts Payable | 3.98M | 3.50M | 3.50M | 5.60M | 13.00M | |||
| Other Current Liabilities | 442.00K | 700.00K | 16.50M | 200.00K | 900.00K | |||
| Total Current Liabilities | 7.22M | 8.70M | 34.80M | 14.50M | 38.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 1.50M | 3.70M | 20.10M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 5.40M | 6.10M | 16.90M | 2.40M | 3.30M | |||
| Total Non-Current Liabilities | 5.40M | 7.50M | 20.60M | 22.50M | 3.40M | |||
| TOTAL LIABILITIES | 12.62M | 16.20M | 55.40M | 37.00M | 41.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -223.45M | -206.00M | -214.10M | -185.60M | -167.90M | |||
| Additional Paid In Capital | 235.61M | 224.00M | 215.20M | 202.20M | 179.70M | |||
| Common Shares | 61.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | N/A | N/A | |||
| Shares Outstanding | 442.46K | 6.50M | 4.90M | 4.40M | 3.20M | |||
| Tangible Book Value per Share | 27.62 | 2.77 | 0.24 | 3.77 | 2.31 | |||
| Total Shareholders' Equity | 12.22M | 18.00M | 1.20M | 16.60M | 11.80M | |||
| TOTAL LIABILITIES AND EQUITY | 24.84M | 34.20M | 56.60M | 53.50M | 53.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.08 | 3.08 | 1.21 | N/A | |||
| Current Ratio | 2.64 | 3.16 | 1.51 | 3.26 | 0.79 | |||
| Return On Assets (ROA) | -70.09% | 23.48% | -50.28% | -33.18% | -75.75% | |||
| Return On Equity (ROE) | -142.47% | 44.61% | -2371.67% | -106.93% | -342.80% | |||
All data in USD